B. Riley analyst Alex Rygiel raised the firm’s price target on RCM Technologies (RCMT) to $37 from $35 and keeps a Buy rating on the shares. RCM’s Q3 results were in line with the firm’s estimates, driven by solid growth across its engineering and healthcare segments, the analyst tells investors in a research note. The company is taking steps to align with various opportunities across all of its segments and expects to continue to drive low double digit earnings growth long-term, B. Riley says.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RCMT:
